Exposure to reversine affects the chondrocyte morphology and phenotype in vitro

J Tissue Eng Regen Med. 2018 Mar;12(3):e1337-e1348. doi: 10.1002/term.2515. Epub 2017 Nov 1.

Abstract

Articular chondrocytes derived from osteoarthritic tissues (OA HAC) show a severely reduced chondrogenic commitment. This impairment undermines their use for tissue-engineered cartilage repair, which relies on cell proliferation and growth to meet therapeutic needs, but also on efficient cell plasticity to recover the chondrogenic phenotype. Reversine (Rev), a 2,6-disubstituted purine inhibitor of spindle-assembly checkpoints, was described to convert differentiated mesenchymal cells to their undifferentiated precursors. We hypothesized that Rev exposure could divert OA HAC to more plastic cells, re-boosting their subsequent commitment. HAC were enzymatically released from OA cartilage specimens, expanded for 2 weeks and treated with 5 μm Rev in dimethylsulphoxide (DMSO) or with DMSO alone for 6 days. Cell growth was assessed using the AlamarBlueTM assay. Cytoskeletal structure, endoproliferation and caspase-3-immunopositivity were assayed by epifluorescence microscopy. The OA HAC chondrogenic performance was evaluated by quantitative reverse transcription-polymerase chain reaction (RT-PCR) for glyceraldehyde-3-phosphate dehydrogenase, Sox9, Aggrecan (Agg), type II collagen (Col2), Ki67, cyclinD1, transforming growth factor-β1 (TGF-β1), -2 and -3, interleukin-1β (IL-1β) and -6 , SMAD3 and -7, and vascular endothelial growth factor. Rev-treated OA HAC recovered polygonal morphology and reduced Ki67 expression and proliferation. Cell-cycle impairment accounted for altered cytoskeletal organization, endoproliferation and apoptosis, whereas a compensatory mechanism sustained the increased cyclinD1 transcript levels. Sox9, Agg and TGFs were overexpressed, but not Col2. IL transcripts were massively downregulated. These events were dose-related and transient. Overall, in spite of a higher Rev-induced transcriptional activity for extracellular matrix components and in spite of a Rev-treated cell phenotype closer to that of the three-dimensional native articular chondrocyte, Rev effects seem unleashed from a full regained chondrogenic potential.

Keywords: articular cartilage; chondrocyte; differentiation; in vitro; reversine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cartilage, Articular
  • Cell Cycle Checkpoints / drug effects
  • Cell Proliferation / drug effects
  • Cell Shape / drug effects*
  • Cells, Cultured
  • Chondrocytes / cytology*
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Cyclin D1 / genetics
  • Cyclin D1 / metabolism
  • Dimethyl Sulfoxide / pharmacology
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Ki-67 Antigen / genetics
  • Ki-67 Antigen / metabolism
  • Male
  • Morpholines / pharmacology*
  • Osteoarthritis / pathology
  • Phenotype
  • Purines / pharmacology*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • SOX9 Transcription Factor / genetics
  • SOX9 Transcription Factor / metabolism
  • Smad3 Protein / genetics
  • Smad3 Protein / metabolism

Substances

  • Ki-67 Antigen
  • Morpholines
  • Purines
  • RNA, Messenger
  • SOX9 Transcription Factor
  • Smad3 Protein
  • Cyclin D1
  • Dimethyl Sulfoxide
  • 2-(4-morpholinoanilino)-6-cyclohexylaminopurine